Clinical Trial Update: A Regulatory Requirement Post-Marketing Surveillance Study to Monitor the Safety and Efficacy of Twynsta (Telmisartan + Amlodipine SPC, q.d.) in Korean Hypertensive Patients Requiring Combination Therapy

View source ↗

Summary

A post-marketing surveillance study evaluating the safety and efficacy of Twynsta (telmisartan + amlodipine) in Korean hypertensive patients on combination ther…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Twynsta (telmisartan/amlodipine)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hypertension | Status: COMPLETED | Results posted: 2018-10-22